Morisawa, Daisuke
Falahatpisheh, Ahmad
Avenatti, Eleonora
Little, Stephen H.
Kheradvar, Arash http://orcid.org/0000-0003-3864-1359
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (1R21EB021513)
American Heart Association (16IRG27250078)
Article History
Received: 26 March 2018
Accepted: 21 September 2018
First Online: 23 October 2018
Competing Interests
: Prof. Kheradvar is the founder of ValVention Inc that aims to commercialize FoldaValve. He also has an equity interest in ValVention Inc, a company that may potentially benefit from the research results. The terms of this arrangement have been reviewed and approved by the University of California, Irvine in accordance with its conflict of interest policies. The other authors have no conflicts of interest to declare.